SSY Group Limited (HKG:2005)
Hong Kong
· Delayed Price · Currency is HKD 2.360
+0.010 (0.43%)
Apr 29, 2026, 4:08 PM HKT
SSY Group Revenue
In the year 2025, SSY Group had annual revenue of 4.17B HKD, down -27.85%. SSY Group had revenue of 2.02B in the half year ending December 31, 2025, a decrease of -35.52%.
Revenue
4.17B
Revenue Growth
-27.85%
P/S Ratio
1.64
Revenue / Employee
730.78K
Employees
5,700
Market Cap
6.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.17B | -1.61B | -27.85% |
| Dec 31, 2024 | 5.77B | -689.76M | -10.67% |
| Dec 31, 2023 | 6.46B | 28.98M | 0.45% |
| Dec 31, 2022 | 6.43B | 1.08B | 20.11% |
| Dec 31, 2021 | 5.36B | 1.10B | 25.72% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Edding Genor Group Holdings | 2.77B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |
| China Shineway Pharmaceutical Group | 3.49B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.51B |
| China Traditional Chinese Medicine Holdings Co. | 16.41B |
| Shandong Xinhua Pharmaceutical Company | 9.74B |
| Luye Pharma Group | 7.02B |
| Ab&B Bio-Tech CO., LTD. JS | 354.77M |
SSY Group News
- 4 weeks ago - SSY Group FY25 Profit Drops On Weak Revenues; Cuts Dividend- Update - Nasdaq
- 6 months ago - SSY Group 9-months Profit Falls - Nasdaq
- 6 months ago - SSY Group Secures Approval For Levamlodipine Besilate Tablets For Hypertension Treatment In China - Nasdaq